- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 207/335 - Radicals substituted by nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 207/335
Total number of patents in this class: 141
10-year publication summary
|
14
|
8
|
10
|
9
|
14
|
7
|
13
|
4
|
7
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Pharma AG | 1085 |
8 |
| Daiichi Sankyo Company, Limited | 1864 |
6 |
| Synact Pharma ApS | 21 |
5 |
| Arena Pharmaceuticals, Inc. | 372 |
4 |
| Grey Wolf Therapeutics Limited | 16 |
4 |
| Janssen Pharmaceutica N.V. | 3624 |
3 |
| Sumitomo Chemical Company, Limited | 8976 |
3 |
| Shanghai Leado PharmaTech Co. Ltd. | 15 |
3 |
| Bristol-myers Squibb Company | 4883 |
2 |
| Applied Materials, Inc. | 17696 |
2 |
| Konica Minolta, Inc. | 8519 |
2 |
| Mitsui Chemicals, Inc. | 3187 |
2 |
| BIAL - Portela & CA, S.A. | 237 |
2 |
| Biocon Limited | 224 |
2 |
| CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 176 |
2 |
| Dainippon Sumitomo Pharma Co., Ltd. | 216 |
2 |
| Exelixis, Inc. | 390 |
2 |
| Nippon Zoki Pharmaceutical Co., Ltd. | 149 |
2 |
| North Carolina State University | 1525 |
2 |
| Proteostasis Therapeutics, Inc. | 72 |
2 |
| Other owners | 81 |